Jacob Späth

Jacob Späth

Student / Programme Doctorate at D-CHAB

ETH Zürich

Pharmaceutical Immunology

HCI G 394

Vladimir-Prelog-Weg 1-5/10

8093 Zürich

Switzerland

Jacob Späth

Research interest

Roles of adhesion molecules in immune cell migration through afferent lymphatics

Education & positions held

2024 - present
Ph.D. student with Prof. Dr. Cornelia Halin Winter, Institute of Pharmaceutical Sciences, Pharmaceutical Immunology, Swiss Federal Institute of Technology (ETH) Zurich, Switzerland

2023 - 2024
Visiting research student with Prof. Michel Dustin PhD, Kennedy Institute of Rheumatology, University of Oxford, United Kingdom

2022 - 2023
Master’s Thesis “GDF-15 fusion proteins as a treatment option for multiple sclerosis” with Prof. Dr. Wischhusen, Experimental Tumor Immunology, University of Würzburg School of Medicine, Germany

2021 - 2024
Master of Science (M.Sc.) in Biochemistry, University of Würzburg, Germany

2021 - 2023
Research assistant with Prof. Dr. Jörg Wischhusen, Experimental Tumor Immunology, University of Würzburg School of Medicine, Germany

2021
Bachelor’s thesis “Expression and characterisation of anti-VCAM-1 Fc GDF-15 fusion proteins” with Prof. Dr. Jörg Wischhusen, Experimental Tumor Immunology, University of Würzburg School of Medicine.

2018 - 2021
Bachelor of Science (B.Sc.) in Biochemistry, University of Würzburg, Germany  

Publications

Haake M, Haack B, Schäfer T, Harter PN, Mattavelli G, Eiring P, Vashist N, Wedekink F, Genssler S, Fischer B, Dahlhoff J, Mokhtari F, Kuzkina A, Welters MJP, Benz TM, Sorger L, Thiemann V, Almanzar G, Selle M, Thein K, Späth J, Gonzalez MC, Reitinger C, Ipsen-Escobedo A, Wistuba-Hamprecht K, Eichler K, Filipski K, Zeiner PS, Beschorner R, Goedemans R, Gogolla FH, Hackl H, Rooswinkel RW, Thiem A, Roche PR, Joshi H, Pühringer D, Wöckel A, Diessner JE, Rüdiger M, Leo E, Cheng PF, Levesque MP, Goebeler M, Sauer M, Nimmerjahn F, Schuberth-Wagner C, von Felten S, Mittelbronn M, Mehling M, Beilhack A, van der Burg SH, Riedel A, Weide B, Dummer R, Wischhusen J. Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. Nat Commun. 2023 Jul 20;14(1):4253. doi: 10.1038/s41467-023-39817-3.  

JavaScript has been disabled in your browser